tirzepatide cardiovascular outcomes trial results july 2025 demonstrates protection in head-to-head with dulaglutide Cardiovascular outcomes of semaglutide and

Infections can linger Inside the body, Cyclospora infections can last for weeks or months

What patients really need is evidence-based care that allows clinicians to adjust dosing over time so were using the right dose for the right patient at the right time. GLP-1 medications can be a game-changer, but they work best when used as part of a broader strategy that includes nutrition, physical activity and long-term support

Thats why we offer comprehensive services including hormone optimization, IV/IM therapy, aesthetic treatments, and ketamine therapy, all designed to help you live your best life

In line with evidence from GLP-1RA studies, tirzepatide exhibited a stabilizing effect on UACR, leading to a least square mean difference of 31.9 (95% CI 37.7 to 25.7) mg/g with insulin glargine [49]

Dehydration, ketosis, fat metabolism, and gut changes can all play a role